A top Foodstuff and Drug Administration (Fda) formal claimed on Thursday that the agency is discovering “what flexibilities we could possibly have” when it arrives the federal government’s marijuana scheduling review directed by President Joe Biden, which she explained as a “very higher priority.” But …